#11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

11/12/20 • 29 min

Imagine if you could turn the characteristics of a cell on and off... or up and down like a volume trigger... constantly tuning things until everything is working just right. It might sound impossible, but that’s exactly what Obsidian therapeutics is working on.
I’ll admit, it was tough for me to wrap my mind around this one at first, but my guest today did a fantastic job of explaining things. So without further ado, chief development officer of Obsidian therapeutics, Catherine Stehman-Breen.
Podcast notes and transcript available here: https://simplebiotechpodcast.com/catherine-stehman-breen-obsidian-therapeutics

-James Ruhle, SimpleBioTechPodcast.com
Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech
If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle

11/12/20 • 29 min

The Simple BioTech Podcast - #11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

Transcript

Speaker 100:00:01.050

As I've learned more and more about the current biotech landscape, I've grown, particularly excited about cell therapy. There's many companies working on cell therapy, but obsidian therapeutics is approaching things differently. Imagine if you could turn the characteristics of a cell on and off or up and down like a volume trigger, constantly tuning things until everything is working just right.

Speaker 100:00:28.589

Generate a badge

Get a badge for your website that links back to this episode

Select type & size

Copy